Additionally, imaging using radiolabeled PSMA molecules (e.g., 68Ga-PSMA), which are overexpressed in the neo-vasculature of the GBM, can enhance the tumor identification and support the selectivity of the proposed approach while reducing the systemic toxicity. This evidence concerns the gene FOLH1 and neoplasm.